» Articles » PMID: 22841930

Informing the Dosing of Interventions in Randomized Trials

Overview
Publisher Elsevier
Date 2012 Jul 31
PMID 22841930
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Dosing is potentially the most important decision that must be made when building or refining behavioral interventions. In this paper, we propose standardized terminology and reporting of dosing information, which would inform intervention development, refinement for dissemination, and systematic reviews of dose-response relationships. Dosing of interventions may be characterized by duration, frequency, and amount. To illustrate the value of operationalizing these three parameters to evaluate dose-response relationships, 31 published reports of behavioral interventions to increase adherence to antiretroviral therapy (ART) were reviewed. The ART literature was characterized by under-reporting of dosing parameters, heterogeneity in dosing schedules, and heterogeneity in type of control group, which complicate analysis of dose-response relationships in systematic review and determination of the optimal dose for intervention dissemination. Improved reporting of the three dosing parameters and comparison of intended to actual delivery can inform the identification of the most effective intervention doses and the efficient implementation of efficacious interventions in clinical practice.

Citing Articles

The role of art knowledge training on aesthetic judgements and executive functions.

Bara I, Cross E, Ramsey R R Soc Open Sci. 2025; 12(2):240175.

PMID: 40012756 PMC: 11858790. DOI: 10.1098/rsos.240175.


Hyped-up or meditate: A scoping review of mindfulness-based group interventions for adolescents with attention deficit hyperactivity disorder.

Tan L, Jones M Clin Child Psychol Psychiatry. 2024; 29(4):1383-1399.

PMID: 39118240 PMC: 11484164. DOI: 10.1177/13591045241272835.


Implementation of Community Health Worker Support for Tobacco Cessation: A Mixed-Methods Study.

Foo C, Potter K, Nielsen L, Rohila A, Maravic M, Schnitzer K medRxiv. 2024; .

PMID: 38343842 PMC: 10854356. DOI: 10.1101/2024.01.26.24301835.


Supporting responsive parenting in real-world implementation: minimal effective dose of the Video Interaction Project.

Piccolo L, Roby E, Canfield C, Seery A, Weisleder A, Cates C Pediatr Res. 2023; 95(5):1295-1300.

PMID: 38040989 PMC: 11423954. DOI: 10.1038/s41390-023-02916-4.


Does Mandala Art Improve Psychological Well-Being in Patients? A Systematic Review.

Zhang M, Liu X, Huang Y J Integr Complement Med. 2023; 30(1):25-36.

PMID: 37668598 PMC: 10801676. DOI: 10.1089/jicm.2022.0780.


References
1.
Purcell D, Latka M, Metsch L, Latkin C, Gomez C, Mizuno Y . Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2008; 46 Suppl 2:S35-47. DOI: 10.1097/QAI.0b013e31815767c4. View

2.
Wagner G, Kanouse D, Golinelli D, Miller L, Daar E, Witt M . Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006; 20(9):1295-302. DOI: 10.1097/01.aids.0000232238.28415.d2. View

3.
Altice F, Maru D, Bruce R, Springer S, Friedland G . Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007; 45(6):770-8. PMC: 2693907. DOI: 10.1086/521166. View

4.
van Servellen G, Nyamathi A, Carpio F, Pearce D, Garcia-Teague L, Herrera G . Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships, and adherence to HAART among low-income HIV-positive Spanish-speaking Latinos. AIDS Patient Care STDS. 2005; 19(11):745-59. DOI: 10.1089/apc.2005.19.745. View

5.
Williams A, Fennie K, Bova C, Burgess J, Danvers K, Dieckhaus K . Home visits to improve adherence to highly active antiretroviral therapy: a randomized controlled trial. J Acquir Immune Defic Syndr. 2006; 42(3):314-21. DOI: 10.1097/01.qai.0000221681.60187.88. View